Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹146.97
Market cap: ₹8,053 Cr
Revenue (annual): ₹1,806 Cr
Net profit (annual): ₹94.88 Cr
P/E (TTM): 57.3×Sector 47.3×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17 Apr 2026 14:20 IST BSE

Morepen Laboratories Regulatory Approval

Morepen Laboratories successfully cleared a USFDA inspection at its Masulkhana, Himachal Pradesh API facility with zero observations (NIL Form 483). This marks the company's fourth consecutive successful inspection over eight years. The clearance reinforces Morepen's quality compliance for exporting APIs to regulated markets including the US and Europe.

Read the filing ↗